MDR and drugs for pediatrics: how to navigate within the regulatory ocean?
What is the regulatory roadmap for paediatric medical devices and drugs before they can be marketed?
i4KIDS I i4KIDS-EUROPE Training Capsule dedicated to learn how to drive innovation through regulatory roadmaps for both Medical Devices Regulation (MDR) and Drugs Regulation with Xavier Luria, a seasoned expert in Medical Devices and Drugs regulation with extensive experience at European Medicines Agency, illuminates strategies to reflect on the regulatory landscape in Europe.
SESSION IN ENGLISH
Related News
Featured
i4KIDS has opened the call for the 3rd edition of its Acceleration Programme 2026, a six‑month initiative designed to fast‑track early‑stage innovations in fetal, paediatric and maternal health. The programme will select seven high‑potential projects and provide training, mentoring, expert consultancy and pitch preparation, culminating in a Demo Day in Barcelona in November 2026. Applications are open until 12 April 2026.
Featured
i4KIDS marked its third consecutive participation at 4YFN, strengthening its position as a leading hub in paediatric and maternal health innovation. In a landmark edition of the congress, the hub showcased emerging technologies, reinforced collaboration with R&I networks and generated new opportunities within a rapidly expanding entrepreneurial ecosystem.
Uncategorized
i4KIDS officially launched its 2026–2028 phase with a Kickoff Meeting that brought together 60 members of the network at Tech Barcelona. The session highlighted the hub’s strategic priorities, upcoming international initiatives and its commitment to driving impactful innovation in paediatric and maternal health.